FDA inspection
AbbVie Inc.: FDA inspection ending Feb 18, 2025
FDA inspection 1230795 · No Action Indicated (NAI) · North Chicago, IL
Key facts
| Inspection ID | 1230795 |
|---|---|
| Firm | AbbVie Inc. |
| FEI number | 3009751352 |
| Address | Drug Analysis Department, 1 N Waukegan Rd |
| City | North Chicago |
| State | IL |
| ZIP | 60064-1802 |
| Fiscal year | 2025 |
| Inspection end date | Feb 18, 2025 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data